SI2848625T1 - Postopki za odstranjevanje kontaminanta z uporabo ionskoizmenjevalne membranske kromatografije z izpodrinjenjem nativnega proteina - Google Patents

Postopki za odstranjevanje kontaminanta z uporabo ionskoizmenjevalne membranske kromatografije z izpodrinjenjem nativnega proteina

Info

Publication number
SI2848625T1
SI2848625T1 SI200832092T SI200832092T SI2848625T1 SI 2848625 T1 SI2848625 T1 SI 2848625T1 SI 200832092 T SI200832092 T SI 200832092T SI 200832092 T SI200832092 T SI 200832092T SI 2848625 T1 SI2848625 T1 SI 2848625T1
Authority
SI
Slovenia
Prior art keywords
contaminant
methods
ion exchange
exchange membrane
membrane chromatography
Prior art date
Application number
SI200832092T
Other languages
English (en)
Slovenian (sl)
Inventor
Arick Brown
Jerome Bill Jr
Timothy Tully
Christopher Dowd
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39899038&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI2848625(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of SI2848625T1 publication Critical patent/SI2848625T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Water Supply & Treatment (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SI200832092T 2008-08-14 2008-08-14 Postopki za odstranjevanje kontaminanta z uporabo ionskoizmenjevalne membranske kromatografije z izpodrinjenjem nativnega proteina SI2848625T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US2008/073179 WO2010019148A1 (en) 2008-08-14 2008-08-14 Methods for removing a contaminant using indigenous protein displacement ion exchange membrane chromatography
EP14189582.1A EP2848625B1 (en) 2008-08-14 2008-08-14 Methods for removing a contaminant using indigenous protein displacement ion exchange membrane chromatography

Publications (1)

Publication Number Publication Date
SI2848625T1 true SI2848625T1 (sl) 2019-11-29

Family

ID=39899038

Family Applications (2)

Application Number Title Priority Date Filing Date
SI200832219T SI3604324T1 (sl) 2008-08-14 2008-08-14 Postopki za odstranjevanje kontaminata z uporabo ionskoizmenjevalne membranske kromatografije z izpodrinjenjem nativnega proteina
SI200832092T SI2848625T1 (sl) 2008-08-14 2008-08-14 Postopki za odstranjevanje kontaminanta z uporabo ionskoizmenjevalne membranske kromatografije z izpodrinjenjem nativnega proteina

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SI200832219T SI3604324T1 (sl) 2008-08-14 2008-08-14 Postopki za odstranjevanje kontaminata z uporabo ionskoizmenjevalne membranske kromatografije z izpodrinjenjem nativnega proteina

Country Status (22)

Country Link
US (2) US10927144B2 (enExample)
EP (3) EP2848625B1 (enExample)
JP (1) JP5666447B2 (enExample)
KR (3) KR20180033311A (enExample)
CN (1) CN102149724B (enExample)
AU (1) AU2008360625C1 (enExample)
BR (1) BRPI0823046B1 (enExample)
CA (1) CA2731943C (enExample)
CY (1) CY1122221T1 (enExample)
DK (2) DK2848625T3 (enExample)
ES (3) ES2749190T3 (enExample)
FI (1) FI3604324T3 (enExample)
HR (2) HRP20240472T1 (enExample)
HU (2) HUE047316T2 (enExample)
IL (2) IL210912B (enExample)
LT (2) LT3604324T (enExample)
MX (1) MX2011001506A (enExample)
PL (2) PL2848625T3 (enExample)
PT (2) PT3604324T (enExample)
RS (1) RS59232B1 (enExample)
SI (2) SI3604324T1 (enExample)
WO (1) WO2010019148A1 (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
KR20090074040A (ko) 2006-09-13 2009-07-03 아보트 러보러터리즈 세포 배양의 개선
HRP20240472T1 (hr) 2008-08-14 2024-06-21 Genentech, Inc. Postupci za eliminaciju kontaminanta uporabom kromatografije membranske ionske izmjene s premještanjem urođenog proteina
EP2350127B1 (en) * 2008-10-20 2015-01-28 AbbVie Inc. Isolation and purification of antibodies using protein a affinity chromatography
AU2009307737B2 (en) 2008-10-20 2015-07-23 Abbvie Inc. Viral inactivation during purification of antibodies
SI2575847T2 (sl) 2010-05-25 2022-08-31 F. Hoffmann-La Roche Ag Tehnike čiščenja polipeptidov
WO2012030512A1 (en) * 2010-09-03 2012-03-08 Percivia Llc. Flow-through protein purification process
KR20140092227A (ko) * 2010-12-10 2014-07-23 트레이시 톰슨 분리 방법용 조성물
US9062106B2 (en) 2011-04-27 2015-06-23 Abbvie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
SG11201403437TA (en) 2011-12-22 2014-07-30 Genentech Inc Ion exchange membrane chromatography
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
US9334319B2 (en) 2012-04-20 2016-05-10 Abbvie Inc. Low acidic species compositions
WO2013158273A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Methods to modulate c-terminal lysine variant distribution
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
US10112971B2 (en) * 2013-02-26 2018-10-30 Agency For Science, Technology And Research Protein purification in the presence of nonionic organic polymers and electropositive surfaces
CA2905010A1 (en) 2013-03-12 2014-09-18 Abbvie Inc. Human antibodies that bind human tnf-alpha and methods of preparing the same
US10023608B1 (en) 2013-03-13 2018-07-17 Amgen Inc. Protein purification methods to remove impurities
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
US9499614B2 (en) 2013-03-14 2016-11-22 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosaccharides
US10400007B2 (en) * 2013-04-16 2019-09-03 Asahi Kasei Medical Co., Ltd. Method for purifying antibody protein
EP3052640A2 (en) 2013-10-04 2016-08-10 AbbVie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
WO2015073884A2 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
US9546208B2 (en) 2014-01-03 2017-01-17 Bio-Rad Laboratories, Inc. Removal of impurities from protein A eluates
DK3510042T3 (da) * 2016-09-07 2024-06-10 Glaxosmithkline Ip Dev Ltd Fremgangsmåde til rensning af antistoffer
WO2018048696A1 (en) 2016-09-09 2018-03-15 3M Innovative Properties Company Functionalized copolymers and use thereof
US10053368B1 (en) * 2017-09-07 2018-08-21 Chevron U.S.A. Inc. Synthesis of AFX framework type molecular sieves
EP3546475A1 (en) * 2018-03-27 2019-10-02 Sanofi Full flow-through process for purifying recombinant proteins
TWI814812B (zh) * 2018-05-02 2023-09-11 美商里珍納龍藥品有限公司 用於評估生化過濾器的適合性的方法
KR102882390B1 (ko) * 2018-06-19 2025-11-05 브리스톨-마이어스 스큅 컴퍼니 크로마토그래피를 사용하여 단백질을 정제하는 방법
CN109324143B (zh) * 2018-10-19 2021-10-29 张骐 利用二维液相分离制备抗体类产品相关杂质的方法
CN109806916B (zh) * 2019-03-15 2021-12-21 中科森辉微球技术（苏州）有限公司 高性能阴离子交换介质及其制备方法
GB201911685D0 (en) * 2019-08-15 2019-10-02 Fujifilm Diosynth Biotechnologies Uk Ltd Process for purifying monoclonal antibodies
KR20220112014A (ko) 2021-02-03 2022-08-10 고인석 십전대보탕을 이용하여 만든 오리목뼈 간식
CN118434753A (zh) * 2021-10-27 2024-08-02 等离子技术有限责任公司 用于分离蛋白质的组合物和方法
CN118290514B (zh) * 2024-06-05 2025-04-04 东曜药业有限公司 基于阴离子膜的抗体偶联药物的纯化方法及抗体偶联药物

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
USRE30985E (en) 1978-01-01 1982-06-29 Serum-free cell culture media
US4515893A (en) 1979-04-26 1985-05-07 Ortho Pharmaceutical Corporation Hybrid cell line for producing complement-fixing monoclonal antibody to human T cells
US4347322A (en) 1981-01-12 1982-08-31 Nabisco Brands, Inc. Chromatographic process for enzyme purification
US4560655A (en) 1982-12-16 1985-12-24 Immunex Corporation Serum-free cell culture medium and process for making same
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
DD266710A3 (de) 1983-06-06 1989-04-12 Ve Forschungszentrum Biotechnologie Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
US4879231A (en) 1984-10-30 1989-11-07 Phillips Petroleum Company Transformation of yeasts of the genus pichia
GB8516415D0 (en) 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells
US5091178A (en) 1986-02-21 1992-02-25 Oncogen Tumor therapy with biologically active anti-tumor antibodies
US4927762A (en) 1986-04-01 1990-05-22 Cell Enterprises, Inc. Cell culture medium with antioxidant
GB8610600D0 (en) 1986-04-30 1986-06-04 Novo Industri As Transformation of trichoderma
IL85035A0 (en) 1987-01-08 1988-06-30 Int Genetic Eng Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
US5091313A (en) 1988-08-05 1992-02-25 Tanox Biosystems, Inc. Antigenic epitopes of IgE present on B cell but not basophil surface
US5720937A (en) 1988-01-12 1998-02-24 Genentech, Inc. In vivo tumor detection assay
EP0420937B1 (en) 1988-06-21 1994-11-09 Genentech, Inc. Therapeutic compositions for the treatment of myocardial infarction
DE68925971T2 (de) 1988-09-23 1996-09-05 Cetus Oncology Corp Zellenzuchtmedium für erhöhtes zellenwachstum, zur erhöhung der langlebigkeit und expression der produkte
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
EP0402226A1 (en) 1989-06-06 1990-12-12 Institut National De La Recherche Agronomique Transformation vectors for yeast yarrowia
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
US5122469A (en) 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
ES2296839T3 (es) 1991-08-14 2008-05-01 Genentech Inc. Variantes de inmunoglobulinas para receptores fc-epsilon especificos.
AU3178993A (en) 1991-11-25 1993-06-28 Enzon, Inc. Multivalent antigen-binding proteins
ATE295420T1 (de) 1992-02-06 2005-05-15 Chiron Corp Marker für krebs und biosynthetisches bindeprotein dafür
AU687755B2 (en) 1992-08-21 1998-03-05 Genentech Inc. Method for treating an LFA-1-mediated disorder
US5736137A (en) 1992-11-13 1998-04-07 Idec Pharmaceuticals Corporation Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
US5595721A (en) 1993-09-16 1997-01-21 Coulter Pharmaceutical, Inc. Radioimmunotherapy of lymphoma using anti-CD20
CA2106612C (en) * 1993-09-21 2001-02-06 Diana Pliura Displacement chromatography process
DK0733207T3 (da) 1993-12-10 1998-04-20 Genentech Inc Fremgangsmåder til diagnose af allergi og screening af anti-allergi-terapeutika
MX9602818A (es) 1994-01-18 1997-06-28 Genentech Inc Un metodo de tratamiento de infeccion parasitaria usando antagonistas ige.
MX9603773A (es) 1994-03-03 1997-07-31 Genentech Inc Anticuerpos monoclonales anti-interleucina-8 para el tratamiento de trastornos inflamatorios.
US5534615A (en) 1994-04-25 1996-07-09 Genentech, Inc. Cardiac hypertrophy factor and uses therefor
IL117645A (en) 1995-03-30 2005-08-31 Genentech Inc Vascular endothelial cell growth factor antagonists for use as medicaments in the treatment of age-related macular degeneration
CA2222231A1 (en) 1995-06-07 1996-12-19 Imclone Systems Incorporated Antibody and antibody fragments for inhibiting the growth of tumors
CA2242414C (en) 1996-01-23 2012-01-03 Genentech, Inc. Anti-cd18 antibodies for use against stroke
CA2242931A1 (en) 1996-01-31 1997-08-07 David Francis Elgar Production of an immunoglobulin enriched fraction from whey protein solutions
US7147851B1 (en) 1996-08-15 2006-12-12 Millennium Pharmaceuticals, Inc. Humanized immunoglobulin reactive with α4β7 integrin
DE69729209T2 (de) 1996-11-27 2005-05-19 Genentech, Inc., South San Francisco Humanisierte anti-koerper gegen cd11a
ATE293640T1 (de) 1997-04-07 2005-05-15 Genentech Inc Anti-vegf antikörper
PT981618E (pt) 1997-05-15 2007-11-23 Genentech Inc ''anticorpo anti-apo-2''
CN103641885A (zh) 1998-05-06 2014-03-19 基因技术股份有限公司 用离子交换层析纯化蛋白质
US6946129B1 (en) 1999-06-08 2005-09-20 Seattle Genetics, Inc. Recombinant anti-CD40 antibody and uses thereof
NZ518477A (en) 1999-10-29 2004-10-29 Genentech Inc Isolated anti-prostate stem cell antigen (PSCA) antibodies that internalise upon binding to PSCA on a mammalian cell, including a PSCA-expressing tumour cell, in vivo
US6479636B1 (en) 2000-04-11 2002-11-12 Honiron Corporation (A Louisiana Corporation) Sugarcane fractioning system
US6633462B2 (en) 2000-07-13 2003-10-14 Koninklijke Philips Electronics N.V. Magnetoresistive angle sensor having several sensing elements
UA83458C2 (uk) 2000-09-18 2008-07-25 Байоджен Айдек Ма Інк. Виділений поліпептид baff-r (рецептор фактора активації в-клітин сімейства tnf)
GB2372464B (en) 2001-02-22 2003-05-14 Vivascience Ltd Method of isolating a charged compound
US7321026B2 (en) 2001-06-27 2008-01-22 Skytech Technology Limited Framework-patched immunoglobulins
AU2002351495A1 (en) 2001-10-17 2003-04-28 Human Genome Sciences, Inc. Neutrokine-alpha and neutrokine-alpha splice variant
US20040093621A1 (en) 2001-12-25 2004-05-13 Kyowa Hakko Kogyo Co., Ltd Antibody composition which specifically binds to CD20
CN101914158A (zh) 2002-02-14 2010-12-15 免疫医疗公司 抗cd 20抗体及其融合蛋白和使用方法
DK1501369T3 (en) * 2002-04-26 2015-09-28 Genentech Inc Non-affinity purification of proteins
EP1561756B1 (en) * 2002-09-11 2015-12-23 Chugai Seiyaku Kabushiki Kaisha Method of purifying protein
CN103709250B (zh) 2002-10-17 2016-08-10 根马布股份公司 抗cd20的人单克隆抗体
EP1944320A1 (en) 2002-12-16 2008-07-16 Genentech, Inc. Immunoglobulin variants and uses thereof
EP1626993B1 (en) 2003-05-09 2015-03-11 Duke University Cd20-specific antibodies and methods of employing same
AR044388A1 (es) 2003-05-20 2005-09-07 Applied Molecular Evolution Moleculas de union a cd20
EP1651663B1 (en) 2003-08-08 2017-05-17 Immunomedics, Inc. Bispecific antibodies for inducing apoptosis of tumor and diseased cells
US8147832B2 (en) 2003-08-14 2012-04-03 Merck Patent Gmbh CD20-binding polypeptide compositions and methods
ES2418830T3 (es) † 2003-10-27 2013-08-16 Wyeth Llc Retirada de agregados de alto peso molecular usando cromatografía de hidroxiapatita
MX2007009466A (es) 2005-02-10 2007-12-07 Baylor Res Inst Anticuerpos monoclonales de anti-interferon alfa y metodos para su uso.
CN104610422A (zh) 2005-03-11 2015-05-13 惠氏公司 弱分配层析的方法
CN101437839A (zh) † 2006-03-20 2009-05-20 米德列斯公司 蛋白质纯化
EP2054521A4 (en) 2006-10-03 2012-12-19 Novo Nordisk As PROCESS FOR CLEANING POLYPEPTIDE CONJUGATES
WO2009135656A1 (en) 2008-05-06 2009-11-12 Lonza Biologics Plc. A method for the purification of antibodies using displacement chromatography
HRP20240472T1 (hr) 2008-08-14 2024-06-21 Genentech, Inc. Postupci za eliminaciju kontaminanta uporabom kromatografije membranske ionske izmjene s premještanjem urođenog proteina
US9813410B2 (en) 2014-06-26 2017-11-07 Rakuten, Inc. Information processing apparatus, information processing method, and information processing program

Also Published As

Publication number Publication date
EP2321337A1 (en) 2011-05-18
DK2848625T3 (da) 2019-10-07
JP5666447B2 (ja) 2015-02-12
KR102196883B1 (ko) 2020-12-30
PT3604324T (pt) 2024-05-10
KR101843915B1 (ko) 2018-04-02
HRP20191848T1 (hr) 2019-12-27
AU2008360625C1 (en) 2017-01-19
AU2008360625A1 (en) 2010-02-18
IL262657A (en) 2018-12-31
ES2527943T5 (es) 2019-03-07
CY1122221T1 (el) 2020-11-25
SI3604324T1 (sl) 2024-06-28
US20120122759A1 (en) 2012-05-17
HK1210181A1 (en) 2016-04-15
EP2321337B2 (en) 2018-10-10
IL262657B (en) 2021-03-25
CA2731943C (en) 2016-11-29
KR20180033311A (ko) 2018-04-02
HRP20240472T1 (hr) 2024-06-21
RS59232B1 (sr) 2019-10-31
EP3604324A1 (en) 2020-02-05
EP2848625A1 (en) 2015-03-18
EP2848625B1 (en) 2019-07-31
CA2731943A1 (en) 2010-02-18
CN102149724A (zh) 2011-08-10
ES2978373T3 (es) 2024-09-11
BRPI0823046B1 (pt) 2021-12-14
ES2527943T3 (es) 2015-02-02
AU2008360625B2 (en) 2016-05-19
FI3604324T3 (fi) 2024-05-16
JP2011530592A (ja) 2011-12-22
HUE047316T2 (hu) 2020-04-28
PL2848625T3 (pl) 2020-01-31
US20210284685A1 (en) 2021-09-16
EP2321337B9 (en) 2016-11-30
CN102149724B (zh) 2014-04-09
IL210912B (en) 2019-03-31
ES2749190T3 (es) 2020-03-19
LT2848625T (lt) 2019-10-10
BRPI0823046A2 (pt) 2015-07-28
MX2011001506A (es) 2011-03-15
PT2848625T (pt) 2019-10-25
LT3604324T (lt) 2024-05-10
KR20110067099A (ko) 2011-06-21
PL3604324T3 (pl) 2024-07-01
DK3604324T3 (da) 2024-04-08
EP2321337B1 (en) 2014-10-22
HUE066562T2 (hu) 2024-08-28
US10927144B2 (en) 2021-02-23
EP3604324B1 (en) 2024-02-28
KR20180137591A (ko) 2018-12-27
WO2010019148A1 (en) 2010-02-18
IL210912A0 (en) 2011-04-28

Similar Documents

Publication Publication Date Title
IL262657B (en) Methods for removing a contaminant using natural protein transfer in ion exchange membrane chromatography
GB2437519B (en) Method for separation
ZA201002497B (en) Method for making contact lenses
IL211217A0 (en) Methods for evaluating chromatography column performance
GB0619534D0 (en) Recap alignment clamp
EP2313172A4 (en) BLOCK CONFIGURATION FOR DISTILLATION ON LARGE SCALE MEMBRANE
GB2462516B (en) Methods for operating a filtration system
EP2170479A4 (en) RECOVERY PROCESS
IL205107A0 (en) Method for purifying fc-fusion proteins
EP2263105A4 (en) METHOD FOR PERFORMING STRAINED POLARIZATION FILTRATION
EP2241095A4 (en) Techniques for transfer error recovery
EP2519536A4 (en) PROTEIN PURIFICATION BY ION EXCHANGE
IL193096A0 (en) End-cap device for high efficiency disposable chromatography column
FR2911793B1 (fr) Procede de separation par chromatographie
EP1979927A4 (en) REDEPOSITION TECHNIQUE FOR MEMBRANE FIXATION
EP2173770A4 (en) METHOD FOR REMOVING ENDOTOXINS FROM PROTEINS
EP2322498A4 (en) PROCESS FOR REMOVING DIBENO FUELS
PL2257537T3 (pl) Sposób oczyszczania epichlorohydryn
EP2216408A4 (en) METHOD FOR IMPROVING SALINITY TOLERANCE
GB0805298D0 (en) SAL (semi-active-laser) target-detection method
GB0616375D0 (en) An apparatus for facilitating disaster recovery
EP2005930A4 (de) Verfahren zur faltenentfernung
PL2134498T3 (pl) Sposób dla procesów autogenicznych
EP2129451A4 (en) METHOD FOR REMOVING STYRENE
FI20065014A0 (fi) Menetelmä betaiinin erottamiseksi